Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Hisamitsu Pharmaceutical Inc

4530
Current price
4 220 JPY -63.12 JPY (-1.49%)
Last closed 4 239 JPY
ISIN JP3784600003
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Tokyo Stock Exchange
Capitalization 312 879 972 278 JPY
Yield for 12 month -5.53 %
1Y
3Y
5Y
10Y
15Y
4530
21.11.2021 - 28.11.2021

Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals in Japan. The company provides external pain-relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; BUTENALOCK, a remedy for athlete's foot; and ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, a transdermal analgesic anti-inflammatory drug; and patches for female hormone, asthma, and overactive bladders. The company exports its products to Asia, the United States of America, and the European area. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan. Address: Tashirodaikan-machi 408, Tosu, Japan, 841-0017

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

694 507.68 JPY

P/E ratio

21.782

Dividend Yield

1.09 %

Current Year

+141 705 999 927 JPY

Last Year

+128 329 999 937 JPY

Current Quarter

+39 646 000 064 JPY

Last Quarter

+35 810 000 023 JPY

Current Year

+78 971 000 068 JPY

Last Year

+72 699 999 924 JPY

Current Quarter

+23 603 999 927 JPY

Last Quarter

+20 805 000 015 JPY

Key Figures 4530

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 19 466 000 320 JPY
Operating Margin TTM 12.25 %
PE Ratio 21.782
Return On Assets TTM 2.48 %
PEG Ratio
Return On Equity TTM 5.5 %
Wall Street Target Price 694 507.68 JPY
Revenue TTM 150 185 000 960 JPY
Book Value 3 730.06 JPY
Revenue Per Share TTM
Dividend Share 128 JPY
Quarterly Revenue Growth YOY 13.7 %
Dividend Yield 1.09 %
Gross Profit TTM 70 067 000 000 JPY
Earnings per share 195.85 JPY
Diluted Eps TTM 195.85 JPY
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY 4.4 %
Profit Margin 9.76 %

Dividend Analytics 4530

Dividend growth over 5 years

-48 %

Continuous growth

1 year

Payout Ratio 5 years average

41 %

Dividend History 4530

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 86
Ex Dividend Date 27.02.2025
Forward Annual Dividend Yield 2 %
Last Split Factor 2:1
Payout Ratio 43.75 %
Last Split Date 27.06.2000
Dividend Date

Stock Valuation 4530

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 21.782
Forward PE
Enterprise Value Revenue 1.251
Price Sales TTM 2.0608
Enterprise Value EBITDA 7.1267
Price Book MRQ 1.1314

Financials 4530

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 4530

For 52 weeks

3 598.25 JPY 4 647.77 JPY
50 Day MA 4 137.28 JPY
Shares Short Prior Month
200 Day MA 3 960.28 JPY
Short Ratio
Shares Short
Short Percent